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Abstract
Background/Aims: Cathepsin S, a protein coded by the CTSS gene, is implicated in adipose tissue biology–this protein
enhances adipose tissue development. Our hypothesis is that common variants in CTSS play a role in body weight
regulation and in the development of obesity and that these effects are influenced by dietary factors–increased by high
protein, glycemic index and energy diets.
Methods: Four tag SNPs (rs7511673, rs11576175, rs10888390 and rs1136774) were selected to capture all common variation
in the CTSS region. Association between these four SNPs and several adiposity measurements (BMI, waist circumference,
waist for given BMI and being a weight gainer–experiencing the greatest degree of unexplained annual weight gain during
follow-up or not) given, where applicable, both as baseline values and gain during the study period (6–8 years) were tested
in 11,091 European individuals (linear or logistic regression models). We also examined the interaction between the CTSS
variants and dietary factors–energy density, protein content (in grams or in % of total energy intake) and glycemic index–on
these four adiposity phenotypes.
Results: We found several associations between CTSS polymorphisms and anthropometric traits including baseline BMI
(rs11576175 (SNP Nu2), p = 0.02, b=20.2446), and waist change over time (rs7511673 (SNP Nu1), p = 0.01, b=20.0433 and
rs10888390 (SNP Nu3), p = 0.04, b=20.0342). In interaction with the percentage of proteins contained in the diet,
rs11576175 (SNP Nu2) was also associated with the risk of being a weight gainer (pinteraction = 0.01, OR= 1.0526)–the risk of
being a weight gainer increased with the percentage of proteins contained in the diet.
Conclusion: CTSS variants seem to be nominally associated to obesity related traits and this association may be modified by
dietary protein intake.
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Introduction
Obesity is caused by a large number of factors that can be
summarized as an interaction between an unhealthy environment
and a predisposing genetic background. There is a wide spectrum
of obesity-susceptibility ranging from strictly genetically deter-
mined obesity to fully environmentally determined obesity with
most individuals containing a complex mix of these factors–i.e.
many individual effects of genes, environmental influences and the
interaction between these two. While epidemiological approaches,
including twin studies, have shown that genetic factors may
account for as much as 57 to 86% of body mass index (BMI)
variations [1], there have been more than 450 genes referenced in
the national canter for biotechnology information ‘‘NCBI gene’’
database (http://www.ncbi.nlm.nih.gov/sites/entrez) as being
associated with obesity, but each of these genes individually has
a small effect on BMI variance. This is very well illustrated by the
results of genome wide association studies on large populations
which have investigated the implication of several hundreds of
thousands of single nucleotide polymorphisms (SNPs) in BMI
variance [2–4]. New variants influencing BMI have been
discovered, yet these variants, even in combination, only explain
a very small part of the observed BMI variations and therefore it
seems that most of the causal variants remain to be discovered. It is
most likely that the largest part of the variance of BMI or other
adiposity related traits attributable to genetic factors is due to a
large number of variants, each of which has a very small effect [5–
7]. Nevertheless, it seems that genes influencing BMI and those
influencing waist circumference and adiposity may belong to a
different pool of genes [8–10]. Furthermore, the genes involved in
BMI and changes in BMI over time might also belong to a
different set of genes [1]. However, the possibility that some genes
may have a pleiotropic effect on several adiposity phenotypes
should not be excluded.
Understanding the mechanisms that underlie development of
adipose tissue will contribute to the identification of novel
candidate genes involved in BMI and fat mass variations during
life. Using a large scale transcriptomic approach in human adipose
tissue, we previously identified Cathepsin S as a putative novel
biomarker of adiposity [11] produced by adipose tissue. Expres-
sion of the CTSS gene, encoding for Cathepsin S, in adipose tissue
correlates with BMI in obese and lean subjects. Clinical studies
also revealed that Cathepsin S circulating levels were correlated
with BMI and triglycerides [11,12]. Furthermore, both CTSS
adipose tissue expression and Cathepsin S systemic circulating
levels were significantly modulated by weight variations either
induced by dietary change or bariatric surgery in independent
studies [12,13]. In vitro studies showed that this protease also has a
local role on adipose tissue. In particular, Cathepsin S contributes
to the stimulation of adipocyte differentiation by degrading
fibronectin, one of the main components of extra cellular matrix
[14]. In vitro studies also showed that CTSS expression and
Cathepsin S secretion in adipose tissue were induced by LPS,
TNF-a, and IL-1b, proinflammatory factors that are secreted by
cells such as macrophages or smooth muscle cells [11]. In addition
Cathepsin S belongs to a family of cystein protease that includes
other proteases involved in the development of obesity. In
particular, CTSK2/2 [15] and CTSL2/2 [16] mice are
protected against diet induced obesity. These animals also have
improved glucose metabolism related parameters [17].
While the metabolic phenotype of CTSS2/2 mice is currently
under investigation, it is not known whether CTSS variants could
influence obesity-related phenotypes.
We recently found an association between obesity related
phenotypes and rs2424577 [18], a variant located in CST3, the
gene that encodes Cystatin C, which is the main endogenous
enzymatic inhibitor of Cathepsins [19–21].
A genetic study carried out by our team showed an association
between several SNPs in CTSS and metabolic features in women.
Rs11576175 was found to be associated with Apo A1 and HDL
levels in a group of lean women from the SUVIMAX [22,23]
study; rs10888390, rs10888394 and rs1136774 were found to be
associated with Apo A1 circulating levels in a group of obese
women [24]. However no consistent association was found
between CTSS variants and BMI in this study, irrespective of the
relatively large sample size (N=2368 unrelated lean and obese
individuals).
Based on these findings, we hypothesize that genetic variation at
the CTSS locus might influence obesity related phenotypes and
their variation over time. We investigated four distinct pheno-
types–BMI (body mass index measured in kilograms per squared
meters), body fat distribution (measured by waist circumference
and waist circumference for given BMI– based on sex-study
stratified initial regressions of waist vs. BMI), change in weight
during follow-up (either as a quantitative outcome or as a binary
weight gainers indicator–experiencing the greatest degree of
unexplained annual weight gain during follow-up or not), and
change in body fat distribution during follow-up (measured by
change in waist circumference and waist circumference for given
BMI during follow-up). These four types of phenotypes were
chosen since they might be influenced by different sets of genes,
although they are all in some way related to adiposity. We
addressed this question in a subset of the EPIC [25] cohorts,
within the DiOGenes [26,27] (Diet Obesity and genes) project
where both possible associations corresponding to CTSS-SNP
main effects and some SNP-dietary interactions (GI, protein intake
and energy density) were investigated. These dietary factors were
chosen since several studies have suggested that diets high in
protein and low in GI were beneficial for obesity prevention and
weight control by enhancing satiety leading to a decreased energy
intake [28,29].
Methods
Ethics Statement
EPIC study has been approved by local review board of all
participating institutions, namely the Florence Local Health
Authority Ethical Committee (Italy), the Ethics Committee of
the Norwich District Health Authority (UK), the Medical Ethics
Committee of TNO (Netherlands Organisation for Applied
Scientific Research) (the Netherlands), the Ethics Committee of
the Medical Association of the State of Brandenburg (Germany),
and the Danish National Committee on Biomedical Research
Ethics (Denmark). Written informed consent has been obtained
from all participants before joining EPIC study.
Participants
Participants came from cohorts established in eight regions
within five European countries (Italy, UK, the Netherlands,
Germany, Denmark) participating in the European Prospective
Investigation into Cancer and Nutrition (EPIC) study [25].The
cohorts were those in the EPIC that had a follow-up program
including reassessment of anthropometry completed. Individuals
were eligible if the following inclusion criteria were met: younger
than 60 years of age at baseline and younger than 65 years at
follow-up, blood sample available, had baseline information on
diet, weight and height and follow-up information on weight,
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stable smoking habits, no cancer, cardiovascular diseases (CVD),
and diabetes, and an annual weight change not more than 5 kg/
year. A reported or recorded weight gain exceeding 5 kg/year is
very unlikely to correspond to increased adiposity but rather much
more likely to either being caused by an error in the measurement,
in the data or emergence of a disease that induces water retention
as oedema or ascites. As such, a total of 50,293 men and women
out of 146,543 initially recruited participants were eligible to
participate in our study.
Cases were defined as those individuals who had experienced
the greatest degree of unexplained annual weight gain during
follow-up (with an average duration of 6–8 years). They were
identified by using the residuals from a regression model of
annual weight change on baseline values of age, weight and
height, smoking status (current/former/never smokers), and
follow-up time. Regression models were run separately for each
sex-country strata. For each of the five countries, except Italy,
we selected 600 male and 600 female cases. As the Italian
cohort consisted of a general population-based sample and of a
women-only sample (population-based breast cancer screening
program), men were underrepresented (27%). Approximately
consistent with the sex-ratio in the Italian cohort, we selected
300 male and 900 female cases. In addition to this a random
subcohort (RSC) sample was selected comprising a random
sample of the total eligible cohort, drawn in such a way that the
total number of noncases should generally equal the number of
cases (with respect to number of individuals and sex-strata
distribution). Since the original case-group sized stratified
random samples resulted in some overlap of cases, in practice
this was performed by random oversampling of noncases, except
in Denmark where overlap between cases and subcohort was
negligible (n = 79). In total, 11,921 participants were included
in the present genetic association study: 6,000 cases and a
subcohort of 7,061 individuals, of which 5,921 were noncases.
The demographic, anthropometric and dietary characteristics of
cases, noncases and random subcohort are presented in Table 1.
We used both a case-noncase group and a random subcohort
group to be able to test for associations with different obesity
related parameters–a categorical (dichotomous) variable in the
case-control group and quantitative variables in the random sub
cohort.
Measurements of Diet, Anthropometrics and Smoking
Status
Validated country-specific food frequency questionnaires
(FFQs) were used to collect dietary information at baseline [25]
on GI and protein intake, assessed using the methods described
earlier [30,31], and energy density.
Details of the anthropometric measurements have been
described previously [30,31]. In brief, at baseline all participants
were measured for weight and height using standard study
protocols [32]. At follow-up, participants in the UK and one
center in the Netherlands (Doetinchem) were measured again by
trained technicians, while all other participants measured their
weight at home according to the guidance provided. Therefore
participants from Doetinchem were analyzed separately from
other Dutch participants. As such, we analyzed the data from six
study centers in five countries. The cohort from Norfolk and one
of the Dutch cohorts used objective measurement, but in the
analyses of the various associations between baseline factors and
weight gain, there were no indication that the association results
were systematically different from the cohorts in which self-
measured weight were used [27,30,31,33].
Information on smoking status (never, former, or current
smoker) was collected via self-administered questionnaires at
baseline and at follow-up. Only those who had not changed their
smoking habits during follow-up were included in the analyses.
Selection of Candidate Genes and tagSNPs
We originally used the International HapMap data for
European ancestry (CEU) (release 20, NCBI Build 35) to select
SNPs such that full coverage of the common genetic variation in
the CTSS gene (+/25 kb) was ensured. We later checked that we
still covered 100% of genetic variability with the latest HapMap
version (HapMap Data Rel 27 Phase II + III, Feb 09 on NCBI
B36 assembly, dbSNP B126).
The Haploview software V3.3 was used to assess the linkage
disequilibrium (LD) structure between SNPs [34]. Tagger software
was used to select tagSNPs with the ‘pairwise tagging only’ option
and an LD measure r2 threshold of 0.8. In total, 4 SNPs were
selected using the pre-requisite criteria based on the minor allele
frequency (MAF) and Hardy-Weinberg Equilibrium (HWE):
MAF$5%, pHWE . 0.01.
Table 1. Characteristics of participants of cases, noncases and subcohort.
Cases (n =5584) Noncases (n =5507) p-values1 Subcohort (n =6566)
Age, yrs 47.667.5 48.067.3 0.003 47.967.3
Sex, %men 45 45 matched 46
Overweight, % 43 39 ,0.0001 39
Obesity, % 17 9 ,0.0001 10
Baseline weight, kg 76.3614.3 72.6613.4 ,0.0001 73.2613.6
Baseline BMI, kg/m2 26.464.2 25.263.6 ,0.0001 25.463.7
Annual weight change, g/yr 1,4286684 306622 ,0.0001 2456801
BMI at follow-up, kg/m2 29.464.4 25.363.5 ,0.0001 25.963.9
Follow-up time, yrs 6.862.5 6.862.5 0.08 6.962.5
Glycemic index (GI) 56.664.3 56.564.1 0.4 56.564.1
Protein intake, g 89.9629.4 89.2627.1 0.2 89.6628.2
Values presented are mean 6 standard deviation or percentage (%) as indicated.
1p-values for the difference between cases and noncases, tested by Student t-test (for continuous variables) or Cochran-Armitage trend test (categorical variables).
doi:10.1371/journal.pone.0040394.t001
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DNA Extraction and Genotyping
Genomic DNA was extracted from the buffy coats with a salting
out method [35], except for participants from the UK, for whom
whole-genome amplified DNA was used. Genomic and amplified
DNA samples were quality-checked, quantified and normalized to
approximately 100 ng/ml and 2.0 mg before genotyping. High
throughput SNP genotyping was carried out using the IlluminaH
GoldenGate Genotyping System at IntegraGen, France.
We subjected all SNPs to country-specific HWE genotype
distribution-tests. Significant deviations from equilibrium were
defined as pHWE# 0.001. This threshold was chosen in order to be
concordant with other genetic studies carried out in the DiOGenes
project. All four SNPs passed the tests for each country and were
successfully genotyped for 11,091 participants. The case group
included 5,584 participants and the random subcohort included
6,566 participants of whom 5,507 were noncases (Table 1).
Genetic Variability at the CTSS Loci
Four tag SNPs were selected in order to obtain a full coverage of
the common variability at the CTSS locus +/25 kb (chromosome
1, 1q21, position 148964178 to 149009929) in the HapMap CEU
population. According to the latest HapMap Data Rel 27 Phase II
+ III, Feb 09 on NCBI B36 assembly dbSNP B126, rs7511673
(SNP Nu1) captured 7 other SNPs–rs1415148, rs12089989,
rs7418501, rs7521898, rs7540874, rs12086472 and rs11587444;
rs11576175 (SNP Nu2) captured no other SNP, rs10888390 (SNP
Nu3) captured 6 other SNPs–rs2275235, rs11204722, rs16827671,
rs3768018, rs4537557 and rs10888391; and rs1136774 (SNP Nu4)
captured 2 other SNPs–rs12568757 and rs11204725. Figure 1
shows the LD pattern for the 4 selected tag SNPs in cases and RSC
respectively. There seems to be no difference in the LD pattern at
the CTSS locus between the cases and RSC. Two tag SNPs–
rs7511373 and rs10888390 (SNP Nu3)–are in strong LD in these
two groups (r2 = 0.83 in both groups). Table 2 provides Hardy-
Weinberg P-values, frequencies and counts for genotypes and
alleles for the 4 SNPs investigated in this study both for the cases
and the RSC. None of these SNPs significantly deviated from
Hardy-Weinberg equilibrium in both the cases and the RSC (all
pHWE.0.05).
Statistical Methods
Each SNP was coded 0, 1 and 2 according to the number of
minor alleles an individual carries (0 for those homozygous for the
common allele, 1 for heterozygote and 2 for those homozygous for
the minor allele).
First, the association between each SNP and each quantita-
tive phenotype was tested using linear regression, assuming an
additive effect of the minor allele. Second, we tested for SNP-
dietary interaction associations with quantitative phenotype in
the same manner. Third, case-noncase (CNC) logistic regression
analyses were run, investigating possible SNP main effects on
case-status (i.e. based on the risk of being a weight-gainer in the
sense outlined above). These logistic regression analyses were
then repeated as described above but including SNP-dietary
effects.
CNC analyses of main effects were not adjusted, whereas
RSC analyses were adjusted for variables that had been
included in the case-status defining model (i.e. baseline values
of age, height, sex, smoking status, and follow-up time) to
reduce the residual variation and potential confounding. SNP-
dietary variable interaction analyses were performed by
including the corresponding interaction term as well as the
Figure 1. Linkage disequilibrium (LD) plot of the CTSS locus in cases and random subcohort. This Figure shows LD (linkage disequilibrium)
values (r2) between each tag SNP in (A) cases and (B) subcohort. Each diamond contains the LD value (r2) between the two SNPs that face each of the
upper sides of the diamond, ex: the LD between rs10888390 (SNP Nu3) and rs1136774 (SNP Nu4) is r2 = 0.62; the darker the diamond, the higher the
LD value. There seems to be no difference in the LD pattern at the CTSS locus between the cases and the subcohort.
doi:10.1371/journal.pone.0040394.g001
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complementary dietary main effect term in the model. Finally,
change-based analyses were additionally adjusted for corre-
sponding baseline values (additionally including baseline BMI
when considering waist circumference for given BMI), and
follow-up time was not used for adjustment when considering
the cross-sectional (baseline) analyses.
All association analyses were first conducted for each study
center separately and then effect-estimates were meta-analyzed.
We used random effects to account for the possible heterogeneity
across study centers, which presence was tested for using the
Cochran Q-test [36].
Nominally significant associations (p,0.05) were retested
assuming a dominant and a recessive model in the same way as
described above.
All association analyses were conducted using Stata 9.2/11.1 for
Windows (StataCorp LP, Texas, USA). The descriptive analyses
were performed with SAS 9.1 for Windows (SAS Institute, Cary,
NC).
Power calculations were performed using QUANTO software,
Version 1.2.4 (May 2009) [37]. In the CNC analysis, the minimum
detectable main effects, at 80% power, were ORs (odds ratios)
1.08 for rs7511673 (SNP Nu1), 1.13 for rs11576175 (SNP Nu2),
and 1.08 for both rs10888390 (SNP Nu3) and rs1136774 (SNP
Nu4). In the RSC analysis, the minimum detectable main effects,
at 80% power, for weight change during the study, were regression
coefficients (b) 40 g/y for rs7511673 (SNP Nu1), 66 g/y for
rs11576175 (SNP Nu2), 41 g/y for rs10888390 (SNP Nu3) and
40 g/y for rs1136774 (SNP Nu4).
Results
Association between CTSS SNPs and BMI at Baseline
We found that the minor allele of rs11576175 (SNP Nu2) was
associated with lower BMI at baseline (p = 0.02, b=20.24, Figure
S1, Table 3). When tested assuming a dominant model, the
association was also significant (p = 0.01, b=20.29, Table S1).
Association between CTSS SNPs and Body Fat
Distribution at Baseline
No significant association between studied SNPs and body fat
distribution were found (Table 3).
Table 2. Description of CTSS variability in subcohort and
cases.
CTSS
random subcohort Cases
n frequency pHWE n frequency pHWE
rs7511673 A/A 2382 0.36 0.93 2016 0.36 0.49
A/T 3142 0.48 2699 0.48
T/T 1041 0.16 869 0.16
A 7906 0.60 6731 0.60
T 5224 0.40 4437 0.40
rs11576175 G/G 5341 0.81 0.39 4571 0.82 0.84
G/A 1155 0.18 960 0.17
A/A 70 0.01 52 0.01
G 11837 0.90 10102 0.90
A 1295 0.10 1064 0.10
rs10888390 G/G 2721 0.41 0.69 2320 0.42 0.63
G/A 2999 0.46 2544 0.46
A/A 844 0.13 717 0.13
G 8441 0.64 7184 0.64
A 4687 0.36 3978 0.36
rs1136774 A/A 1833 0.28 0.76 1606 0.29 0.15
A/G 3283 0.50 2727 0.49
G/G 1448 0.22 1250 0.22
A 6949 0.53 5939 0.53
G 6179 0.47 5227 0.47
Genotype and allele counts, genotype and allele frequencies and Hardy
Weinberg Equilibrium test p-values for each SNP in the subcohort and in the
cases respectively.
doi:10.1371/journal.pone.0040394.t002
Table 3. Associations between CTSS SNPs, BMI and body fat distribution at baseline.
SNP Phenotype Estimate P SE CI 95% lower CI 95% higher
rs7511673 (SNP Nu1) BMI 20.03 0.62 0.06 20.15 0.09
Waist 20.08 0.65 0.16 20.40 0.25
Waist for given BMI 0.00 0.95 0.08 20.16 0.15
rs11576175 (SNP Nu2) BMI 20.24 0.02 0.10 20.45 20.04
Waist 20.50 0.06 0.27 21.03 0.02
Waist for given BMI 0.13 0.31 0.13 20.13 0.39
rs10888390 (SNP Nu3) BMI 20.01 0.93 0.07 20.14 0.13
Waist 0.00 1.00 0.17 20.33 0.33
Waist for given BMI 0.03 0.67 0.08 20.13 0.20
rs1136774 (SNP Nu4) BMI 20.09 0.22 0.07 20.23 0.05
Waist 20.16 0.36 0.18 20.51 0.19
Waist for given BMI 0.08 0.30 0.08 20.07 0.24
Overall Meta analysis estimates (b), p values, standard error and 95% confidence intervals for association between SNPs and BMI and body fat distribution at baseline in
the random subcohort.
doi:10.1371/journal.pone.0040394.t003
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Association between CTSS SNPs and Annual Weight
Change
The interaction between rs11576175 (SNP Nu2) and the
percentage of proteins contained in the diet was significantly
associated to case-status (interaction p= 0.01, OR=1.05, Table 4).
For each additional minor allele, the estimated risk of being a weight
gainer increases by 1.05 odds per extra one percent of proteins in the
diet. This association was also significant in this population when
assuming a dominant model (p= 0.004, OR=1.06, Table S1).
Association between CTSS SNPs and Annual Body Fat
Distribution Change
Both rs7511673 (SNP Nu1) and rs10888390 (SNP Nu3) were
associated with annual waist change (p = 0.01, b=20.04, Figure
Table 4. Association between CTSS SNPs and weight change during the study.
SNP Phenotype Effect Estimate P SE CI 95% lower CI 95% higher
rs7511673 (SNP Nu1) Weight (RSC) main effect 215.52 0.19 11.85 238.74 7.70
interaction diet ED 231.53 0.47 44.12 2117.99 54.94
interaction diet GI 22.79 0.42 3.49 29.63 4.05
interaction diet protein 20.22 0.61 0.44 21.08 0.64
interaction diet protein % 23.48 0.49 5.09 213.46 6.51
Case/noncase main effect 0.99 0.79 0.03 0.93 1.06
interaction diet ED 0.94 0.50 0.10 0.77 1.13
interaction diet GI 0.99 0.17 0.01 0.97 1.00
interaction diet protein 1.00 0.47 0.00 1.00 1.00
interaction diet protein % 1.00 0.98 0.01 0.97 1.03
rs11576175 (SNP Nu2) Weight (RSC) main effect 31.71 0.09 18.89 25.32 68.73
interaction diet ED 213.88 0.85 73.59 2158.11 130.36
interaction diet GI 21.62 0.81 6.63 214.62 11.37
interaction diet protein 0.18 0.87 1.06 21.89 2.25
interaction diet protein % 5.60 0.53 8.93 211.91 23.10
Case/noncase main effect 0.99 0.75 0.05 0.90 1.08
interaction diet ED 0.94 0.77 0.20 0.63 1.40
interaction diet GI 1.00 0.99 0.02 0.97 1.03
interaction diet protein 1.00 0.14 0.00 1.00 1.01
interaction diet protein % 1.05 0.01 0.02 1.01 1.09
rs10888390 (SNP Nu3) Weight (RSC) main effect 210.13 0.40 12.09 233.83 13.57
interaction diet ED 220.92 0.64 44.92 2108.96 67.13
interaction diet GI 0.13 0.98 4.42 28.54 8.79
interaction diet protein 20.24 0.66 0.53 21.28 0.81
interaction diet protein % 22.73 0.64 5.89 214.26 8.81
Case/noncase main effect 0.99 0.85 0.04 0.92 1.07
interaction diet ED 0.91 0.34 0.10 0.75 1.10
interaction diet GI 0.99 0.24 0.01 0.97 1.01
interaction diet protein 1.00 0.23 0.00 1.00 1.00
interaction diet protein % 1.00 0.76 0.01 0.98 1.03
rs1136774 (SNP Nu4) Weight (RSC) main effect 5.51 0.64 11.64 217.30 28.32
interaction diet ED 240.39 0.35 43.40 2125.45 44.67
interaction diet GI 21.03 0.82 4.46 29.78 7.72
interaction diet protein 20.02 0.98 0.85 21.69 1.65
interaction diet protein % 0.25 0.97 6.75 212.98 13.48
Case/noncase main effect 1.00 0.90 0.03 0.95 1.05
interaction diet ED 0.90 0.28 0.09 0.75 1.09
interaction diet GI 0.99 0.23 0.01 0.98 1.01
interaction diet protein 1.00 0.96 0.00 1.00 1.00
interaction diet protein % 1.02 0.23 0.01 0.99 1.04
Overall Meta analysis estimates (b or odd ratios), p values, standard error and 95% confidence intervals for association between SNPs and weight change during the
study, ED: energy density, GI: glycemic index. RSC: random subcohort.
doi:10.1371/journal.pone.0040394.t004
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S2, Table 5 and p= 0.04, b=20.03, Figure S3, Table 5
respectively). Rs7511673 (SNP Nu1) was associated with a change
in waist circumference of 0.04 cm per year and per minor allele
and rs10888390 (SNP Nu3) was associated with a change in waist
circumference of 0.03 cm per year and per minor allele.
Nevertheless these two SNPs are in strong LD in our populations
(r2 = 0.83, Figure 1). The association between rs7511673 (SNP
Nu1) and waist gain was significant when assuming a dominant
model (p = 0.02, b=20.06, Table S1). Rs7511673 (SNP Nu1) was
also associated with change in waist circumference for given BMI
(p = 0.03, b=20.03, Figure S4, Table 5)–rs7511673 (SNP Nu1)
was associated with a change in waist circumference of 0.03 cm
per year and per minor allele. This association was significant
when assuming a dominant model (p = 0.02, b=20.04, Table S1).
Table 5. Association between CTSS SNPs and body fat distribution change during the study.
SNP Phenotype Effect Estimate P SE CI 95% lower CI 95% higher
rs7511673 (SNP Nu1) Waist (RSC) main effect 20.04 0.01 0.02 20.08 20.01
interaction diet ED 0.02 0.75 0.06 20.10 0.14
interaction diet GI 0.00 0.75 0.01 20.02 0.01
interaction diet protein 0.00 0.43 0.00 0.00 0.00
interaction diet protein % 0.00 0.79 0.01 20.02 0.01
Waist for given BMI main effect 20.03 0.03 0.01 20.05 0.00
(RSC) interaction diet ED 0.04 0.44 0.05 20.05 0.12
interaction diet GI 0.00 0.72 0.01 20.02 0.01
interaction diet protein 0.00 0.26 0.00 0.00 0.00
interaction diet protein % 0.00 0.61 0.01 20.01 0.01
rs11576175 (SNP Nu2) Waist (RSC) main effect 0.01 0.82 0.03 20.05 0.06
interaction diet ED 20.01 0.91 0.10 20.21 0.19
interaction diet GI 0.00 0.68 0.01 20.03 0.02
interaction diet protein 0.00 0.31 0.00 0.00 0.00
interaction diet protein % 0.02 0.16 0.01 20.01 0.04
Waist for given BMI main effect 0.00 0.98 0.02 20.04 0.04
(RSC) interaction diet ED 20.05 0.50 0.07 20.20 0.10
interaction diet GI 20.01 0.24 0.01 20.02 0.01
interaction diet protein 0.00 0.32 0.00 0.00 0.00
interaction diet protein % 0.02 0.14 0.01 20.01 0.04
rs10888390 (SNP Nu3) Waist (RSC) main effect 20.03 0.04 0.02 20.07 0.00
interaction diet ED 0.02 0.72 0.06 20.10 0.15
interaction diet GI 0.00 0.95 0.01 20.01 0.02
interaction diet protein 0.00 0.31 0.00 0.00 0.00
interaction diet protein % 0.00 0.85 0.01 20.01 0.02
Waist for given BMI main effect 20.02 0.06 0.01 20.05 0.00
(RSC) interaction diet ED 0.03 0.48 0.05 20.06 0.12
interaction diet GI 0.00 0.71 0.01 20.02 0.01
interaction diet protein 0.00 0.22 0.00 0.00 0.00
interaction diet protein % 0.00 0.90 0.01 20.01 0.01
rs1136774 (SNP Nu4) Waist (RSC) main effect 20.02 0.18 0.02 20.05 0.01
interaction diet ED 20.01 0.92 0.06 20.13 0.11
interaction diet GI 0.00 0.73 0.01 20.01 0.01
interaction diet protein 0.00 0.96 0.00 0.00 0.00
interaction diet protein % 0.01 0.43 0.01 20.01 0.02
Waist for given BMI main effect 20.02 0.24 0.01 20.04 0.01
(RSC) interaction diet ED 0.00 0.96 0.05 20.10 0.09
interaction diet GI 0.00 0.53 0.01 20.02 0.01
interaction diet protein 0.00 0.36 0.00 0.00 0.00
interaction diet protein % 0.00 0.70 0.01 20.01 0.01
Overall Meta analysis estimates (b or odd ratios), p values, standard error and 95% confidence intervals for associations between SNPs and body fat distribution change
during the study, ED: energy density, GI: glycemic index. RSC: random subcohort.
doi:10.1371/journal.pone.0040394.t005
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Discussion
In this study we found several associations between CTSS
polymorphisms and anthropometric parameters including baseline
BMI (rs11576175 (SNP Nu2)), waist change over time (rs7511673
(SNP Nu1) and rs10888390 (SNP Nu3)). Although this waist
change (0.03–0.04 cm/yr) is unlikely to have clinical relevance if
considered on its own, this association should rather be considered
in combination with other risk factors. Importantly rs11576175
(SNP Nu2) was also associated with the risk of being a weight
gainer, and this association was under the influence of the
percentage of proteins contained in the diet. Rs7511673 (SNP
Nu1) captured 7 other SNPs and rs10888390 (SNP Nu3) captured
6 other SNPs, besides this, two tag SNPs–rs7511673 (SNP Nu1)
and rs10888390 (SNP Nu3)–are in LD in both of our study groups
(r2 = 0.83 in each group), which means that any association with
one of these variants could be caused by one of at least 14 other
SNPs. There is a controversy regarding the role of fat intake on
obesity related phenotypes–some studies found that fat intake had
an important role [38] whereas others found that it had no
importance at all [39–49]. Furthermore a study carried out in the
EPIC cohorts, which investigated the role of fat intake on body
weight change yielded no significant association between the type
or amount of dietary fat and weight change [50]. For this reason,
we decided not to investigate the interaction between CTSS SNPs
and the type or amount of dietary fat in our study.
Many statistical tests have been performed therefore the
question of multiple testing should be raised. The p-values
presented in our study are uncorrected in order to avoid
conservative corrections and loss of power (after correcting by
an FDR adjustment [51] (data not shown) none of the p-values
were significant). A further – although largely overlapping –
motivation for not restricting the presentation and discussion to p-
values adjusted for multiple comparisons is that our study is
exploratory; therefore our results will need to be replicated in large
independent cohorts (for related discussion, see e.g. [52,53]).
Our group has previously published an association between
CTSS variants and lipid metabolism related parameters [24]. In
addition, we identified an association between a genetic variant
located in CST3, a gene coding for an endogenous inhibitor of
Cathepsin S, and BMI measured repeatedly during lifetime in
independent European populations [18]. These observations
suggest that potential alterations of Cathepsin pathway, eventually
genetically induced, might contribute to changes in corpulence
over time and are therefore consistent with the observations
reported in this present paper. The obesity related phenotypes of
CTSK2/2 [15] and CTSL2/2 [16] mice are also in agreement
with this hypothesis [17]. Fontanesi et al [54] found an association
between a CTSS polymorphism and feed:gain ratio and average
daily gain in a group of Italian large white pigs. These findings
seem to be in agreement with ours.
Noteworthy, CTSS has not been identified as associated to
obesity related parameters by the large GWAS [2,9]. However this
may be due to the fact that these studies focus on one time point
and do not investigate longitudinal data, therefore the genes that
influence changes in corpulence may not be detectable by these
approaches. Moreover, these studies do not account for dietary
habits. Finally, it might be that these associations were not
identified by GWAS simply because of the small effect size of the
associations–although GWAS include many more individuals than
in our study, the significance level that is generally applied in
GWAS is much lower than the one applied in our study (0.05). We
cannot exclude that these associations are caused by one or several
variants acting on a gene nearby CTSS. CTSK, the gene that codes
for Cathepsin K, an enzyme that is also involved in obesity [17], is
located in the same genomic region as CTSS (1q21) [55–57]. In the
HapMap CEU population, CTSSrs11576175 (SNP Nu2) is in
perfect LD with CTSKrs4379678 (r2 = 1), which means that the
associations we found with rs11576175 (SNP Nu2) might actually
reflect an association with rs4379678. Furthermore we have
identified a complex association between rs11576175 (SNP Nu2)
and the risk of being a weight gainer–the interaction between
rs11576175 (SNP Nu2) and the percentage of proteins in the diet
was associated with the risk of being a weight gainer. A potential
link between high protein diet and improved weight and fat loss
has been reported [58]. These observations may be explained by
the fact that proteins might be more satiating than fat or
carbohydrate [59]. Very little is known concerning the molecular
mechanisms underlying this process and especially regarding the
potential link between Cathepsins, and in particular Cathepsin S,
and dietary protein intake. The possibility that dietary changes
could influence the expression of Cathepsins has been highlighted
by the outcomes of both animal models and in vitro studies. In
mice, after infection by Paracoccidioides brasiliensis (a fungus that
causes Paracoccidioidomycosis, a systemic mycosis), a very high
protein diet was associated with a greater increase in spleen and
liver Cathepsin G mRNA than a low protein diet [60].
Furthermore, in vitro, pyridoxal phosphate, a coenzyme form of
vitamin B6, strongly inhibits Cathepsin B activity and weakly
inhibits Cathepsin S and K activities [61].
In conclusion, we have identified nominally significant associ-
ations between several CTSS variants and obesity related
parameters. One of these associations seems to be influenced by
dietary protein intake. However this link needs to be further
investigated in order to gain knowledge on the mechanisms
governing weight homeostasis.
Supporting Information
Figure S1 BMI at baseline according to rs11576175
(SNP N62). Mean +/2 SEM of BMI at baseline according to
rs11576175 genotypes (G/G n=5341, G/A n= 1155, and A/A
n=70) in the subcohort, n = 6566. Rs11576175 was associated
with a decrease of 0.24 kg/m2 per A allele (p = 0.02, b=20.24).
(TIF)
Figure S2 Annual waist gain according to rs7511673
(SNP N61). Mean +/- SEM of annual waist gain according to
rs7511673 genotypes (A/A n= 2382, A/T, n= 3142, and T/T,
n= 1041) in the subcohort, n = 6566. In the regression analysis
rs7511673 was associated with a decrease in waist circumference
of 0.04 cm per year and per T allele (p = 0.01, b=20.04). This
association was also significant when assuming a dominant model
(p = 0.02, b=20.06), A/T and T/T carriers gained 0.06 cm per
year less than A/A carriers.
(TIF)
Figure S3 Annual waist gain according to rs10888390
(SNP N63). Mean +/2 SEM of annual waist gain according to
rs10888390 genotypes (G/G n=2721, G/A n= 2999, and A/A
n=844) in the subcohort, n = 6566. rs10888390 was associated
with a decrease in waist circumference of 0.03 cm per year and
per A allele (p = 0.04, b=20.03).
(TIF)
Figure S4 Annual waist for given BMI gain per year
according to rs7511673 (SNP N61). Mean +/2 SEM of
annual waist gain for given BMI according to rs7511673
genotypes (A/A n= 2382, A/T, n= 3142, and T/T, n= 1041)
in the subcohort, n = 6566. Rs7511673 was associated with a
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decrease in waist circumference for given BMI of 0.03 cm per year
and per T allele (p = 0.03, b=20.03). This association was also
significant when assuming a dominant model (p = 0.02,
b=20.04).
(TIF)
Table S1 Dominant and recessive models for associa-
tions which were significant when assuming an additive
model.
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